Joint Research Centre European Commission
Dr. Uboldi has obtained her PhD in Biology at the Westfälische Wilhelms Universität in Münster (Germany), where she has investigated the role of L-selectin in the immunopathogenesis of autoimmune experimental encephalomyelitis, an animal model for multiple sclerosis. As postdoctoral research fellow she has joined the Institute of Pathology at the University Medical Centre of the Johannes Gutenberg University in Mainz (Germany), where she has started investigating the potential in vitro toxicity exerted by nanosized materials in a model of the human alveolo-capillary barrier. Dr. Uboldi then moved, as Post-doc, at the Joint Research Centre of the European Community (Ispra, Italy), where she continues investigating nanoparticles and their potential cytotoxicity, genotoxicity and morphological transformation in vitro, in addition to their uptake and intracellular localization.
In vitro toxicity (cytotoxicity, genotoxicity, morphological transformation), Nanomaterials, Microscopy and Cytokine release.